Tan Xiao-Rong, Li Juan, Chen Hua-Wei, Luo Wei, Jiang Nan, Wang Zheng-Bo, Wang Shuai
Oncological Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinjiang Medical University, School/Hospital of Stomatology Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China.
Department of Oncology, Daping Hospital, Army Medical University, Chongqing 400042, China.
World J Clin Cases. 2023 Mar 6;11(7):1498-1505. doi: 10.12998/wjcc.v11.i7.1498.
Liver metastasis is the most common form of distant metastasis in colorectal cancer, and the only possible curative treatment for patients with colorectal liver metastases (CRLM) is hepatectomy. However, approximately 25% of patients with CRLM have indications for liver resection at the initial diagnosis. Strategies aimed at downstaging large or multifocal tumors to enable curative resection are appealing.
A 42-year-old man was diagnosed with ascending colon cancer and liver metastases. Due to the huge lesion size and compression of the right portal vein, the liver metastases were initially diagnosed as unresectable lesions. The patient was treated with preoperative transcatheter arterial chemoembolization (TACE) consisting of 5-fluorouracil/Leucovorin/oxaliplatin/Endostar. After four courses, radical right-sided colectomy and ileum transverse colon anastomosis were performed. Postoperatively, the pathological analysis revealed moderately differentiated adenocarcinoma with necrosis and negative margins. Thereafter, S7/S8 partial hepatectomy was performed after two courses of neoadjuvant chemotherapy. Pathological examination of the resected specimen revealed a pathologically complete response (pCR). Intrahepatic recurrence was detected more than two months after the operation, and the patient was then treated with TACE consisting of irinotecan/Leucovorin/fluorouracil therapy plus Endostar. Subsequently, the patient was treated with a γ-knife to enhance local control. Notably, a pCR was reached, and the patient's overall survival time was > 9 years.
Multidisciplinary treatment can promote the conversion of initially unresectable colorectal liver metastasis and facilitate complete pathological remission of liver lesions.
肝转移是结直肠癌最常见的远处转移形式,而肝切除术是结直肠癌肝转移(CRLM)患者唯一可能的治愈性治疗方法。然而,约25%的CRLM患者在初诊时就有肝切除指征。旨在使大肿瘤或多灶性肿瘤降期以实现根治性切除的策略很有吸引力。
一名42岁男性被诊断为升结肠癌伴肝转移。由于病变巨大且压迫右门静脉,肝转移灶最初被诊断为不可切除病变。患者接受了由氟尿嘧啶/亚叶酸钙/奥沙利铂/恩度组成的术前经动脉化疗栓塞(TACE)治疗。四个疗程后,进行了根治性右半结肠切除术和回肠横结肠吻合术。术后病理分析显示为中度分化腺癌伴坏死,切缘阴性。此后,在进行了两个疗程的新辅助化疗后,进行了S7/S8部分肝切除术。切除标本的病理检查显示病理完全缓解(pCR)。术后两个多月检测到肝内复发,然后患者接受了由伊立替康/亚叶酸钙/氟尿嘧啶治疗加恩度组成的TACE治疗。随后,患者接受了伽马刀治疗以加强局部控制。值得注意的是,达到了pCR,患者的总生存时间>9年。
多学科治疗可促进最初不可切除的结直肠癌肝转移的转化,并促进肝脏病变的完全病理缓解。